Code | 2195D | ||||||||||
MA number | EU/1/19/1371/001 | ||||||||||
Product Form: | con inf 1x30 ml/300 mg (liek.inj.skl.) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 30 | ||||||||||
Route of admin.: | Intravenous use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 8(3) application - new active substance |
MA issued: | 02.07.2019 |
Validity: | 02.07.2024 |
SmPC + PL: | European Medicines Agency's database |
Dokument: | Ultomiris_Karta pacienta.pdf |
Dokument: | Ultomiris_Prirucka pre lekarov.pdf |
Dokument: | Ultomiris_Prirucka pre pacienta, rodicov a zakonnych zastupcov pacienta.pdf |
Safety feature | Yes |
Data update: | 04.07.2023 |